Microenvironmental Interactions in Chronic Lymphocytic Leukemia: The Master Role of CD49d

被引:37
作者
Dal Bo, Michele [1 ]
Tissino, Erika [1 ]
Benedetti, Dania [1 ]
Caldana, Chiara [1 ]
Bomben, Riccardo [1 ]
Del Poeta, Giovanni [2 ,3 ]
Gaidano, Gianluca [4 ]
Rossi, Francesca Maria [1 ]
Zucchetto, Antonella [1 ]
Gattei, Valter [1 ]
机构
[1] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, I-33081 Aviano, PN, Italy
[2] S Eugenio Hosp, Div Hematol, Rome, Italy
[3] Univ Roma Tor Vergata, Rome, Italy
[4] Amedeo Avogadro Univ Eastern Piedmont, Dept Clin & Expt Med, Div Hematol, Novara, Italy
关键词
B-CELL RECEPTOR; TYROSINE KINASE INHIBITOR; IN-SITU HYBRIDIZATION; MARROW STROMAL CELLS; BONE-MARROW; ALPHA-4-BETA-1; INTEGRIN; ANTIGEN-RECEPTOR; LYMPH-NODES; SPONTANEOUS APOPTOSIS; DEPENDENT REGULATION;
D O I
10.1053/j.seminhematol.2014.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease characterized by the accumulation/expansion of a clonal population of neoplastic cells with the morphologic appearance of small mature B lymphocytes in blood, bone marrow, and lymphoid organs. A combination of genetic lesions is primarily responsible for the first step(s) of neoplastic transformation, along with microenvironmental signals, which concurrently operate by enhancing proliferation and/or inhibiting apoptosis. In this context, CD49d is known to play a pivotal role in mediating both cell-cell and cell-matrix interactions in CLL-involved tissues, eventually delivering pro-survival signals and protecting CLL cells from drug-induced damages. In the present review, we address, in detail, CD49d activities in the CLL microenvironment, CD49d functional and physical interactions with other microenvironmental receptors (including CD38 and B-cell receptor), and the relationship of CD49d expression with specific cytogenetic features in CLL. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:168 / 176
页数:9
相关论文
共 96 条
[1]   α4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo [J].
Arroyo, AG ;
Yang, JT ;
Rayburn, H ;
Hynes, RO .
IMMUNITY, 1999, 11 (05) :555-566
[2]   The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression [J].
Baudot, A. D. ;
Jeandel, P. Y. ;
Mouska, X. ;
Maurer, U. ;
Tartare-Deckert, S. ;
Raynaud, S. D. ;
Cassuto, J. P. ;
Ticchioni, M. ;
Deckert, M. .
ONCOGENE, 2009, 28 (37) :3261-3273
[3]   Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons [J].
Bauvois, B ;
Dumont, J ;
Mathiot, C ;
Kolb, JP .
LEUKEMIA, 2002, 16 (05) :791-798
[4]   Vav promotes differentiation of human tumoral myeloid precursors [J].
Bertagnolo, V ;
Brugnoli, F ;
Mischiati, C ;
Sereni, A ;
Bavelloni, A ;
Carini, C ;
Capitani, S .
EXPERIMENTAL CELL RESEARCH, 2005, 306 (01) :56-63
[5]   Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study [J].
Bomben, Riccardo ;
Dal Bo, Michele ;
Capello, Daniela ;
Forconi, Francesco ;
Maffei, Rossana ;
Laurenti, Luca ;
Rossi, Davide ;
Del Principe, Maria Ilaria ;
Zucchetto, Antonella ;
Bertoni, Francesco ;
Rossi, Francesca Maria ;
Bulian, Pietro ;
Cattarossi, Ilaria ;
Ilariucci, Fiorella ;
Sozzi, Elisa ;
Spina, Valeria ;
Zucca, Emanuele ;
Degan, Massimo ;
Lauria, Francesco ;
Del Poeta, Giovanni ;
Efremov, Dimitar G. ;
Marasca, Roberto ;
Gaidano, Gianluca ;
Gattei, Valter .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (04) :492-506
[6]   Differential Bone Marrow Homing Capacity of VLA-4 and CD38 High Expressing Chronic Lymphocytic Leukemia Cells [J].
Brachtl, Gabriele ;
Sahakyan, Karine ;
Denk, Ursula ;
Girbl, Tamara ;
Alinger, Beate ;
Hofbauer, Sebastian W. ;
Neureiter, Daniel ;
Hofbauer, Josefina Pinon ;
Egle, Alexander ;
Greil, Richard ;
Hartmann, Tanja Nicole .
PLOS ONE, 2011, 6 (08)
[7]   Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia [J].
Buchner, Maike ;
Baer, Constance ;
Prinz, Gabriele ;
Dierks, Christine ;
Burger, Meike ;
Zenz, Thorsten ;
Stilgenbauer, Stephan ;
Jumaa, Hassan ;
Veelken, Hendrik ;
Zirlik, Katja .
BLOOD, 2010, 115 (22) :4497-4506
[8]   Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9 [J].
Buggins, Andrea G. S. ;
Levi, Ana ;
Gohil, Satyen ;
Fishlock, Keith ;
Patten, Piers E. M. ;
Calle, Yolanda ;
Yallop, Deborah ;
Devereux, Stephen .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (02) :216-222
[9]   Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-kB Activation and De novo Gene Transcription [J].
Buggins, Andrea G. S. ;
Pepper, Chris ;
Patten, Piers E. M. ;
Hewamana, Saman ;
Gohil, Satyen ;
Moorhead, Jane ;
Folarin, Najeem'deen ;
Yallop, Deborah ;
Thomas, N. Shaun B. ;
Mufti, Ghulam J. ;
Fegan, Chris ;
Devereux, Stephen .
CANCER RESEARCH, 2010, 70 (19) :7523-7533
[10]   CD49d Is the Strongest Flow Cytometry-Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia [J].
Bulian, Pietro ;
Shanafelt, Tait D. ;
Fegan, Chris ;
Zucchetto, Antonella ;
Cro, Lilla ;
Nueckel, Holger ;
Baldini, Luca ;
Kurtova, Antonina V. ;
Ferrajoli, Alessandra ;
Burger, Jan A. ;
Gaidano, Gianluca ;
Del Poeta, Giovanni ;
Pepper, Chris ;
Rossi, Davide ;
Gattei, Valter .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) :897-+